AFRICA HEALTH NEWS
A WHITAKER GROUP PUBLICATIONSEPTEMBER/OCTOBER 2008
WHO R
EGIONAL
C
OMMITTEE
FOR
A
FRICA
AFRICA COMMENDED ONHEALTH CARE ADVANCES
Dr. Margaret Chan, Director-General of the World Health Organiza-tion (WHO), has commended African governments on their leadershipin advancing health care across the continent.At the opening of the 58th session of the Regional Committee forAfrica on September 1, 2008, in Yaoundé, Cameroon, Dr. Chan said,“You have demonstrated that, with enough commitment and support,truly anything can be done.”She noted that with nearly three million people in low and middleincome countries now receiving antiretroviral treatment for AIDS - the vast majority of them in Africa - a milestone had been reached. “Whatmany considered impossible has now been achieved. Drug prices candrop. Complex interventions can be delivered in resource-poor settings.Patients can adhere to treatment regimens. Treatment outcomes here inAfrica can be just as good as anywhere else in the world,” she said.Dr. Chan gave special recognition to Kenya, Malawi and Rwanda fortheir “striking progress” in integrating HIV and tuberculosis services.Such integration, she said, pointed the way forward and gave an impe-tus to improving the efficiency of health services.She also gave an upbeat assessment of the continent’s success in re-cent years in introducing underutilized vaccines. By the end of 2008,she reported, all but five countries will have introduced the Hib (Hae-mophilus influenza type B) vaccine. Next year, Gambia, Kenya andRwanda plan to introduce the new pneumococcal immunization.“Right now, every country in the region is including the hepatitis B vaccine, which also protects against liver cancer, in routine immuni-zation,” Dr. Chan said. “If you can maintain the current commitment,liver cancer will drop off the list of leading health problems in our life-time. is will be true progress for public health.”Dr. Chan also pointed to the tremendous scaling up of funding forhealth care in Africa as cause for optimism. Public and private fundinghas more than doubled this century, she said, from $6.5 billion in 2000to $16.7 billion in 2006. And, she added, that aid is being used far moreeffectively than ever before.“e major funding agencies are now combining the purchase inter- ventions with funds to strengthen systems for their delivery,” Dr. Chansaid. “International partnerships and health initiatives now recognizethat progress depends on strengthened health infrastructures and ser- vice delivery.”Delegates at the session included African health ministers, expertsfrom the health sector and leading stakeholders from multinational in-stitutions, NGOs and the global pharmaceutical industry.
Partnerships
Global Health Progress, an initiative that fosters partnerships be-tween research-based biopharmaceutical companies and global healthleaders to improve health in the developing world, co-hosted a workingdinner on September 4 with e Whitaker Group (TWG) for Minis-ters of Health, heads of delegation and other senior delegates attendingthe WHO Africa Committee session. Nearly 100 delegates, including10 African Ministers of Health and representatives from 28 Africancountries, discussed the theme, “Global Resources Aligned Against Ne-glected Tropical Diseases.”TWG moderated the discussion which followed the official openingof the dinner by the Honorable André Mama Fouda, Minister for PublicHealth for Cameroon. Additional speakers included Dr. Joseph Kamg-no, Technical Advisor for the National Cameroon Onchocerciasis Con-trol Program and Director of the Filariasis Research Center in Yaoundé,Professor Wilfred M’bacham, Associate Professor of Public Health andBiotechnology, University of Yaoundé, and Mr. Alain Aumonier, Direc-tor of International Relations for sanofi-aventis and Chairman of thePublic Health Advisory Committee, International Federation of Phar-maceutical Manufacturers and Associations (IFPMA).Speakers highlighted the successes of ongoing public-private part-nerships for health in Cameroon as well as existing commitments by theglobal research-based pharmaceutical industry to address health chal-lenges in Africa. Participants also received copies of the latest healthresource guide developed by Global Health Progress to assist Minis-ters and senior health officials with up-to-date information on availablehealth care resources and programs.Global Health Progress serves as a global convening point for publichealth officials and global health stakeholders to engage, lend advocacy to shared goals, identify best practices for programs that address healthneeds, and facilitate partnership and research and development effortsto fight neglected diseases in the developing world.
Health ministersfrom countries of theAfrican Meningitis Beltadopted the YaoundéDeclaration at the WHORegional Committee forAfrica session.
e Declaration com-mits them to implement-ing comprehensive men-ingitis control plans; toundertake joint actionto address the threat; toimprove information ex-change for epidemic re-sponse; and to contributefinancially to activities tocontrol epidemics.A new vaccine is expected to be introduced in Burkina Fasoin 2009-2010 and will be phased into an additional 24 coun-tries between 2010 and 2015.
THE YAOUNDÉ DECLARATION
A child in Sudan is vaccinated against meningitis
Leave a Comment